Afaxys Pharma Birth Control Pills

Our Products

We know birth control isn’t one-size-fits-all. That’s why we provide a broad portfolio of contraceptive and adjacent product options. Our offerings include oral contraceptives, an emergency contraceptive, an injectable contraceptive, a contraceptive patch, and a vaginal ring. For a full list of our products and their equivalents, see below.

For more information on how to order, click here.


Annovera Product Packaging

ANNOVERA®

(segesterone acetate and ethinyl estradiol vaginal system)
Delivers 0.15 mg/0.013 mg per day

NDC#

50261-313-01

WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS
See full prescribing information for complete boxed warning.

  • Females over 35 years old who smoke should not use ANNOVERA.
  • Cigarette smoking increases the risk of serious cardiovascular events from combination hormonal contraceptive use.
Learn More View Full Prescribing Information, Including Boxed Warning

Visit the ANNOVERA website here.


Aubra EQ Product Packaging

Aubra EQ®

(levonorgestrel and ethinyl estradiol tablets, USP) 0.1 mg/0.02 mg

Compares to

Aubra®, Aviane®, Falmina™, Lutera®, and Orsythia®

NDC#

50102-220-23

WARNING

Cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. This risk increases with age and with the extent of smoking (in epidemiologic studies, 15 or more cigarettes per day was associated with a significantly increased risk) and is quite marked in women over 35 years of age. Women who use oral contraceptives should be strongly advised not to smoke.

Learn More View Full Prescribing Information, Including Boxed Warning

Chateal EQ Product Packaging

Chateal EQ®

(levonorgestrel and ethinyl estradiol tablets, USP) 0.15 mg/0.03 mg

Compares to

Altavera™, Chateal®, Kurvelo™, Levora®, Marlissa®, and Portia®

NDC#

50102-230-23

WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS
Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive (COC) use. This risk increases with age particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, COCs, including Chateal EQ, are contraindicated in women who are over 35 years of age and smoke.

Learn More View Full Prescribing Information, Including Boxed Warning

Cyred EQ Product Packaging

Cyred EQ®

(desogestrel and ethinyl estradiol tablets, USP) 0.15 mg/0.03 mg

Compares to

Apri®, Cyred®, Emoquette®, Enskyce™, Isibloom™, and Reclipsen™

NDC#

50102-254-23

WARNING: CARDIOVASCULAR RISK ASSOCIATED WITH SMOKING

Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive (COC) use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, combination oral contraceptives, including Cyred EQ, should not be used by women over 35 years of age and smoke.

Learn More View Full Prescribing Information, Including Boxed Warning

EContra One Step Package

EContra One-Step®

(levonorgestrel) tablet, 1.5 mg – OTC

Other 1.5 mg levonorgestrel emergency contraceptive products include: Aftera®, AfterPill®, EContra® EZ, My Way®, Opcicon™ One-Step, Plan B One-Step®, and Take Action®

NDC#

50102-211-13

Learn More View Full Product Information

Jasmiel Product Packaging

Jasmiel®

(drospirenone and ethinyl estradiol tablets, USP) 3 mg/0.02 mg

Compares to

Gianvi®, Loryna™, Nikki™, and Yaz®

NDC#

50102-240-23

WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS
Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive (COC) use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, COCs are contraindicated in women who are over 35 years of age and smoke.

Learn More View Full Prescribing Information, Including Boxed Warning

Lidocaine Hydrochloride Injection, USP

Lidocaine Hydrochloride Injection, USP 1% Vials

NDC#

50102-400-10

Learn More View Full Prescribing Information

Lyleq Product Packaging

Lyleq®

(norethindrone tablets, USP) 0.35 mg

Compares to

Camila®, Heather®, Incassia®, Nor-QD®, and Tulana

NDC#

50102-300-13

WARNING

Cigarette smoking greatly increases the possibility of suffering heart attacks and strokes. Women who use oral contraceptives are strongly advised not to smoke.

Learn More View Full Prescribing Information, Including Boxed Warning

MedroxyPROGESTERone Product Packaging

MedroxyPROGESTERone acetate injectable suspension, USP

150 mg/mL for intramuscular use

Compares To

Depo-Provera®

NDC#

50102-591-40

WARNING: LOSS OF BONE MINERAL DENSITY

  • Women who use medroxyprogesterone acetate injectable suspension may lose significant bone mineral density. Bone loss is greater with increasing duration of use and may not be completely reversible.
  • It is unknown if use of medroxyprogesterone acetate injectable suspension during adolescence or early adulthood, a critical period of bone accretion, will reduce peak bone mass and increase the risk for osteoporotic fracture in later life.
  • Medroxyprogesterone acetate injectable suspension is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate.
Learn More View Full Prescribing Information, Including Boxed Warning

Tarina 24 Fe Product Packaging

Tarina® 24 Fe

(norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets) 1 mg/20 mcg and 75 mg

Compares to

Blisovi™ 24 Fe, Junel® Fe 24, and Larin™ 24 Fe

NDC#

50102-224-23

WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS

Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptives (COC) use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, COCs should not be used by women who are over 35 years of age and smoke.

Learn More View Full Prescribing Information, Including Boxed Warning

Tarina Fe 1/20 EQ Product Packaging

Tarina Fe 1/20 EQ®

(norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets) 1 mg/20 mcg and 75 mg

Compares to

Junel® Fe 1/20, Larin™ Fe 1/20, Microgestin® Fe 1/20, and Tarina® Fe 1/20

NDC#

50102-228-23

WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS

Cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. This risk increases with age and with heavy smoking (15 or more cigarettes per day) and is quite marked in women over 35 years of age. Women who use oral contraceptives should be strongly advised not to smoke.

Learn More View Full Prescribing Information, Including Boxed Warning

Tri-VyLibra Product Packaging

Tri-VyLibra®

(norgestimate and ethinyl estradiol tablets, USP) 0.180 mg/0.035 mg, 0.215 mg/0.035 mg, and 0.250 mg/0.035 mg

Compares to

Tri-Estarylla™, Tri-Linyah®, Tri-Mili™, Tri-Previfem®, Tri-Sprintec®, and TriNessa®

NDC#

50102-233-13

WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS

Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive (COC) use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, COCs are contraindicated in women who are over 35 years of age and smoke.

Learn More View Full Prescribing Information, Including Boxed Warning

Tri-VyLibra Lo Product Packaging

Tri-VyLibra® Lo

(norgestimate and ethinyl estradiol tablets, USP) 0.180 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.250 mg/0.025 mg

Compares to

Tri-Lo-Estarylla™, Tri-Lo-Marzia™, and Tri-Lo-Sprintec®

NDC#

50102-231-13

WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS

Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive (COC) use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, COCs are contraindicated in women who are over 35 years of age and smoke.

Learn More View Full Prescribing Information, Including Boxed Warning

Twirla

Twirla®

(levonorgestrel and ethinyl estradiol) transdermal system 120 mcg/day levonorgestrel and 30 mcg/day ethinyl estradiol

NDC#

71671-100-03

WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS and CONTRAINDICATED IN WOMEN WITH A BMI ≥30 kg/m2

Cigarette Smoking and Serious Cardiovascular Events
Cigarette smoking increases the risk of serious cardiovascular events from combined hormonal contraceptive (CHC) use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, CHCs, including TWIRLA, are contraindicated in women who are over 35 years of age and smoke.

Contraindicated in Women with a BMI ≥30 kg/m2
TWIRLA is contraindicated in women with a BMI ≥30 kg/m2. Compared to women with a lower BMI, women with a BMI ≥30 kg/m2 had reduced effectiveness and may have a higher risk for venous thromboembolic events (VTEs).

Learn More View Full Prescribing Information, Including Boxed Warning

Visit the TWIRLA website here.


VyLibra Product Packaging

VyLibra®

(norgestimate and ethinyl estradiol tablets, USP) 0.250 mg/0.035 mg

Compares to

Estarylla™, Mili®, Mono-Linyah™, MonoNessa®, Ortho-Cyclen®, Previfem®, and Sprintec®

NDC#

50102-235-13

WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS

Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive (COC) use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, COCs are contraindicated in women who are over 35 years of age and smoke.

Learn More View Full Prescribing Information, Including Boxed Warning

Need help? Contact an Afaxys Account Manager